Cullinan Therapeutics Inc Sustainability Reports
Cullinan Therapeutics, Inc. is a biopharmaceutical company focused on developing a diversified portfolio of targeted therapies for cancer and autoimmune diseases. The company designs clinical-stage assets that either inhibit key disease drivers or activate the immune system to eliminate diseased cells.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00HW2DGR3
2 reports from 2023 to 2024
Company Profile
Cullinan Therapeutics, Inc. is a biopharmaceutical company focused on developing a diversified portfolio of targeted therapies for cancer and autoimmune diseases. The company designs clinical-stage assets that either inhibit key disease drivers or activate the immune system to eliminate diseased cells.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
